Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Synthesis, spectroscopic, topological, hirshfeld surface analysis, and anti-covid-19 molecular docking investigation of isopropyl 1-benzoyl-4-(benzoyloxy)-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate
Arulraj Ramalingam, K. Murugavel, Sivakumar Sambandam, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10831-e10831
Open Access | Times Cited: 50
A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites
Md. Jahirul Islam, Nafisa Nawal Islam, Md. Siddik Alom, et al.
Immunobiology (2022) Vol. 228, Iss. 1, pp. 152302-152302
Open Access | Times Cited: 35
SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, et al.
Genomics (2022) Vol. 114, Iss. 5, pp. 110466-110466
Open Access | Times Cited: 29
Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review
Yun Zhao, Ying Tang, Qi Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Design and in-silico evaluation of PNA-based novel pronucleotide analogues targeting RNA-dependent RNA polymerase to combat COVID-19
Kiran Shehzadi, Iqra Kalsoom, Mingjia Yu, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-23
Closed Access
Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
Zhonglei Wang, Liyan Yang, Xian‐En Zhao
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4684-4701
Open Access | Times Cited: 36
Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins
Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6394-6394
Open Access | Times Cited: 25
In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor
Faez Iqbal Khan, Fakhrul Hassan, Dakun Lai
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 22
Investigation of Molecular Interactions Mechanism of Pembrolizumab and PD-1
Simiao Wang, Faez Iqbal Khan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10684-10684
Open Access | Times Cited: 13
Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A Computational Study
Cecep Suhandi, Siti Sarah Alfathonah, Aliya Nur Hasanah
Molecules (2023) Vol. 28, Iss. 13, pp. 5187-5187
Open Access | Times Cited: 13
Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp
M. Murali, Hittanahallikoppal Gajendramurthy Gowtham, Mohammad Azam Ansari, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 12, pp. 969-980
Closed Access | Times Cited: 16
Carvacrol instigates intrinsic and extrinsic apoptosis with abrogation of cell cycle progression in cervical cancer cells: Inhibition of Hedgehog/GLI signaling cascade
Afza Ahmad, Rohit Kumar Tiwari, Mοhd Saeed, et al.
Frontiers in Chemistry (2023) Vol. 10
Open Access | Times Cited: 9
Interactive deciphering electron-shuttling characteristics of Coffea arabica leaves and potential bioenergy-steered anti-SARS-CoV-2 RdRp inhibitor via microbial fuel cells
Po‐Wei Tsai, Lemmuel L. Tayo, Jasmine U. Ting, et al.
Industrial Crops and Products (2022) Vol. 191, pp. 115944-115944
Open Access | Times Cited: 14
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
Ahmed O. Mohammed, Mazin I. Abo-Idrees, Alaa A. Makki, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1553-1567
Open Access | Times Cited: 12
The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein
Faez Iqbal Khan, Kevin A. Lobb, Dakun Lai
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
The Key Site Variation and Immune Challenges in SARS-CoV-2 Evolution
Ying Liu, Qing Ye
Vaccines (2023) Vol. 11, Iss. 9, pp. 1472-1472
Open Access | Times Cited: 5
Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies
Zia ur Rehman, Asim Najmi
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10489-10509
Closed Access | Times Cited: 5
Casiopeinas® as SARS-CoV-2 main protease (Mpro) inhibitors: a combined DFT, molecular docking and ONIOM approach
Miguel Reina, Luis Gabriel Talavera-Contreras, Yeshenia Figueroa-DePaz, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 26, pp. 12500-12511
Closed Access | Times Cited: 9
Identifying repurposed drugs as potential inhibitors of Apolipoprotein E: A bioinformatics approach to target complex diseases associated with lipid metabolism and neurodegeneration
Mohammad Furkan, M. S. Khan, Moyad Shahwan, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129167-129167
Closed Access | Times Cited: 1
Computational investigation of remdesivir, favipiravir, ribavirin, and their phosphate derivatives against Nipah virus RNA-dependent RNA polymerase
Vishal S. Patil, Sanjay Deshpande, Darasaguppe R. Harish, et al.
Molecular Simulation (2024) Vol. 50, Iss. 15, pp. 1170-1182
Closed Access | Times Cited: 1
Bioprospection for antiviral compounds from selected medicinal plants against RNA polymerase of rotavirus A using molecular modelling and density functional theory
Adedayo Ayodeji Lanrewaju, Abimbola M. Enitan, Saheed Sabiu, et al.
Chemical Physics Impact (2024), pp. 100745-100745
Open Access | Times Cited: 1
Inclusion Complexation of Remdesivir with Cyclodextrins: A Comprehensive Review on Combating Coronavirus Resistance—Current State and Future Perspectives
Arumugam Anitha, Rajaram Rajamohan, Moorthiraman Murugan, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4782-4782
Open Access | Times Cited: 1
Molecular Insights into Structural Dynamics and Binding Interactions of Selected Inhibitors Targeting SARS-CoV-2 Main Protease
Yuanyuan Wang, Yulin Zhou, Faez Iqbal Khan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13482-13482
Open Access | Times Cited: 1
A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2
Udit Chaube, Bhumika Patel, Hardik Bhatt
3 Biotech (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top